Aethon Therapeutics jobs and careers

aethontx.com LinkedIn

About Aethon Therapeutics

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer-associated mutations.

Biotechnology Health Care Product Research

Founded: 2022
Employees: 1 to 10
Total funding: $30M

Leadership

The top of Aethon Therapeutics's org chart, with how many people report into each leader.

RC

Raj Chopra

CEO

5 reports

PJ

Paul Da Silva Jardine

Chief Scientific Officer

3 reports

CR

Christoph Rader

Chief Technology Officer

Board

SH

Seth Harrison

Chairman

SK

Shohei Koide

Co-Founder & Scientific Advisor

BN

Benjamin Neel

Co-Founder & Scientific Advisor

Jobs at Aethon Therapeutics

No open positions right now. Explore more companies on TheJobsMap.